241 related articles for article (PubMed ID: 28154332)
1. [A New Pain Regulatory System via the Brain Long Chain Fatty Acid Receptor GPR40/FFA1 Signal].
Nakamoto K
Yakugaku Zasshi; 2017; 137(2):199-204. PubMed ID: 28154332
[TBL] [Abstract][Full Text] [Related]
2. Hypothalamic GPR40 signaling activated by free long chain fatty acids suppresses CFA-induced inflammatory chronic pain.
Nakamoto K; Nishinaka T; Sato N; Mankura M; Koyama Y; Kasuya F; Tokuyama S
PLoS One; 2013; 8(12):e81563. PubMed ID: 24349089
[TBL] [Abstract][Full Text] [Related]
3. [The role of brain n-3 fatty acids-GPR40/FFAR1 signaling in pain].
Nakamoto K; Tokuyama S
Nihon Yakurigaku Zasshi; 2018; 151(1):21-26. PubMed ID: 29321392
[TBL] [Abstract][Full Text] [Related]
4. Regulation of prohormone convertase 2 protein expression via GPR40/FFA1 in the hypothalamus.
Nakamoto K; Aizawa F; Nishinaka T; Tokuyama S
Eur J Pharmacol; 2015 Sep; 762():459-63. PubMed ID: 26071852
[TBL] [Abstract][Full Text] [Related]
5. The activation of supraspinal GPR40/FFA1 receptor signalling regulates the descending pain control system.
Nakamoto K; Nishinaka T; Sato N; Aizawa F; Yamashita T; Mankura M; Koyama Y; Kasuya F; Tokuyama S
Br J Pharmacol; 2015 Mar; 172(5):1250-62. PubMed ID: 25362997
[TBL] [Abstract][Full Text] [Related]
6. [Antinociceptive effect of docosahexaenoic acid (DHA) through long fatty acid receptor G protein-coupled receptor 40 (GPR40)].
Nakamoto K; Nishinaka T; Sato N; Mankura M; Koyama Y; Tokuyama S
Yakugaku Zasshi; 2014; 134(3):397-403. PubMed ID: 24584021
[TBL] [Abstract][Full Text] [Related]
7. Activation of GPR40 produces mechanical antiallodynia via the spinal glial interleukin-10/β-endorphin pathway.
Mao XF; Wu HY; Tang XQ; Ali U; Liu H; Wang YX
J Neuroinflammation; 2019 Apr; 16(1):84. PubMed ID: 30981281
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the long-chain fatty acid receptor GPR40 as a novel pain regulatory system.
Nakamoto K; Nishinaka T; Matsumoto K; Kasuya F; Mankura M; Koyama Y; Tokuyama S
Brain Res; 2012 Jan; 1432():74-83. PubMed ID: 22137657
[TBL] [Abstract][Full Text] [Related]
9. [Elucidation of mechanisms underlying docosahexaenoic acid-induced antinociception].
Nishinaka T; Matsumoto K; Nakamoto K; Anbo A; Mankura M; Koyama Y; Tokuyama S
Yakugaku Zasshi; 2013; 133(5):493-9. PubMed ID: 23649389
[TBL] [Abstract][Full Text] [Related]
10. Involvement of GPR40, a long-chain free fatty acid receptor, in the production of central post-stroke pain after global cerebral ischemia.
Harada S; Haruna Y; Aizawa F; Matsuura W; Nakamoto K; Yamashita T; Kasuya F; Tokuyama S
Eur J Pharmacol; 2014 Dec; 744():115-23. PubMed ID: 25281202
[TBL] [Abstract][Full Text] [Related]
11. [A long chain fatty acid receptor GPR40 as a novel pain control system].
Nakamoto K; Tokuyama S
Nihon Shinkei Seishin Yakurigaku Zasshi; 2012 Aug; 32(4):233-7. PubMed ID: 23012892
[TBL] [Abstract][Full Text] [Related]
12. Targeting FFA1 and FFA4 receptors in cancer-induced cachexia.
Freitas RDS; Muradás TC; Dagnino APA; Rost FL; Costa KM; Venturin GT; Greggio S; da Costa JC; Campos MM
Am J Physiol Endocrinol Metab; 2020 Nov; 319(5):E877-E892. PubMed ID: 32893672
[TBL] [Abstract][Full Text] [Related]
13. Ligands at Free Fatty Acid Receptor 1 (GPR40).
Hara T
Handb Exp Pharmacol; 2017; 236():1-16. PubMed ID: 27757762
[TBL] [Abstract][Full Text] [Related]
14. Dysfunctional GPR40/FFAR1 signaling exacerbates pain behavior in mice.
Nakamoto K; Aizawa F; Miyagi K; Yamashita T; Mankura M; Koyama Y; Kasuya F; Hirasawa A; Kurihara T; Miyata A; Tokuyama S
PLoS One; 2017; 12(7):e0180610. PubMed ID: 28723961
[TBL] [Abstract][Full Text] [Related]
15. Attenuation of inflammatory and neuropathic pain behaviors in mice through activation of free fatty acid receptor GPR40.
Karki P; Kurihara T; Nakamachi T; Watanabe J; Asada T; Oyoshi T; Shioda S; Yoshimura M; Arita K; Miyata A
Mol Pain; 2015 Feb; 11():6. PubMed ID: 25889021
[TBL] [Abstract][Full Text] [Related]
16. Linoleic acid activates GPR40/FFA1 and phospholipase C to increase [Ca2+]i release and insulin secretion in islet beta-cells.
Zhou YJ; Song YL; Zhou H; Li Y
Chin Med Sci J; 2012 Mar; 27(1):18-23. PubMed ID: 22734209
[TBL] [Abstract][Full Text] [Related]
17. The role of polyunsaturated fatty acids and GPR40 receptor in brain.
Khan MZ; He L
Neuropharmacology; 2017 Feb; 113(Pt B):639-651. PubMed ID: 26005184
[TBL] [Abstract][Full Text] [Related]
18. Activity of dietary fatty acids on FFA1 and FFA4 and characterisation of pinolenic acid as a dual FFA1/FFA4 agonist with potential effect against metabolic diseases.
Christiansen E; Watterson KR; Stocker CJ; Sokol E; Jenkins L; Simon K; Grundmann M; Petersen RK; Wargent ET; Hudson BD; Kostenis E; Ejsing CS; Cawthorne MA; Milligan G; Ulven T
Br J Nutr; 2015 Jun; 113(11):1677-88. PubMed ID: 25916176
[TBL] [Abstract][Full Text] [Related]
19. Identification and pharmacological characterization of multiple allosteric binding sites on the free fatty acid 1 receptor.
Lin DC; Guo Q; Luo J; Zhang J; Nguyen K; Chen M; Tran T; Dransfield PJ; Brown SP; Houze J; Vimolratana M; Jiao XY; Wang Y; Birdsall NJ; Swaminath G
Mol Pharmacol; 2012 Nov; 82(5):843-59. PubMed ID: 22859723
[TBL] [Abstract][Full Text] [Related]
20. The fatty acid receptor FFA1/GPR40 a decade later: how much do we know?
Mancini AD; Poitout V
Trends Endocrinol Metab; 2013 Aug; 24(8):398-407. PubMed ID: 23631851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
